Inventor · disambiguated record
Ritu Lal
Also filed as: LAL RITU
12 granted patents·7 pending applications·40 citations·filing 2014–2025
89Inventor score
Files withGEN1E LIFESCIENCES INC16UNIV LELAND STANFORD JUNIOR2BOARD OF TRUSTEES OF LELAND STANFORD JR UNIV1
Top patents by PatentIndex Score
19 records- 0196US11286260B2P38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2021·Granted Mar 29, 2022·12 cites·30 claims
- 0295US11555020B2Substituted naphthyl p38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted Jan 17, 2023·4 cites·22 claims
- 0395US11440918B2p38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted Sep 13, 2022·5 cites·29 claims
- 0495US11390581B2Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrateGEN1E LIFESCIENCES INC·Filed 2021·Granted Jul 19, 2022·2 cites·27 claims
- 0591US11926635B2P38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted Mar 12, 2024·1 cites·35 claims
- 0688US12116353B1Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydrochloride saltGEN1E LIFESCIENCES INC·Filed 2024·Granted Oct 15, 2024·2 cites·15 claims
- 0784US12331024B2Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2024·Granted Jun 17, 2025·0 cites·32 claims
- 0882US12404259B2Inhibitors of extracellular signal-regulated kinaseGEN1E LIFESCIENCES INC·Filed 2024·Granted Sep 2, 2025·0 cites·12 claims
- 0982US2024182486A1P38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2024·Application pending·0 cites
- 1081US9956113B2Method and system for regulating core body temperatureBOARD OF TRUSTEES OF LELAND STANFORD JR UNIV·Filed 2014·Granted May 1, 2018·11 cites·8 claims
- 1179US11976049B2Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted May 7, 2024·0 cites·17 claims
- 1279US2025270176A1Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2025·Application pending·0 cites
- 1377US11191667B2Method and system for regulating core body temperatureUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Dec 7, 2021·3 cites·19 claims
- 1477US2025353826A1Inhibitors of extracellular signal-regulated kinaseGEN1E LIFESCIENCES INC·Filed 2025·Application pending·0 cites
- 1574US2025243154A1Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrateGEN1E LIFESCIENCES INC·Filed 2025·Application pending·0 cites
- 1673US12269792B2Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl) phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrateGEN1E LIFESCIENCES INC·Filed 2022·Granted Apr 8, 2025·0 cites·20 claims
- 1771US2025333387A1Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydrochloride saltGEN1E LIFESCIENCES INC·Filed 2024·Application pending·0 cites
- 1868US2025095774A1Machine learning methods and systems for acute respiratory distress syndrome patient sub-phenotypingGEN1E LIFESCIENCES INC·Filed 2024·Application pending·0 cites
- 1963US2022087860A1Method and system for regulating core body temperatureUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ritu Lal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →